Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFκB activation offering protection against chemically induced diabetes

Free Radical Biology and Medicine

Volumn 28, Issue 4, 2000, Pages 604-614

  Ho, Emily ^a   Chen, Gouman ^b   Bray, Tammy M ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

^c Cambell Hall 347 ^*  (United States)

Author keywords

Antioxidants; Free radicals; IDDM; NF B; Spin trap

Indexed keywords

ALLOXAN; ANTIOXIDANT; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N TERT BUTYL ALPHA PHENYLNITRONE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SPIN TRAPPING; STREPTOZOCIN DIABETES;

ALLOXAN; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FREE RADICALS; HYPERGLYCEMIA; ISLETS OF LANGERHANS; MALE; MICE; NF-KAPPA B; NITROGEN OXIDES; REACTIVE OXYGEN SPECIES; SPIN LABELS; STREPTOZOCIN;

EID: 0034652424     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00271-3     Document Type: Article

References (50)

1. Scott F.W., Marliss E.B. Conference summary diet as an environmental factor in development of insulin-dependent diabetes mellitus. Can. J. Physiol. Pharmacol. 69:1991;311-319.
2. Zonana J., Rimoin D.L. Inheritance of diabetes mellitus. N. Engl. J. Med. 295:1976;603-605.
3. Adams D.D., Adams Y.J., Knight J.G., McCall J., White P., Horrocks R., van Loghem E. A solution to the genetic and environmental puzzles of insulin-dependent diabetes mellitus. Lancet. 1:1984;420-442.
4. Oberley L.W. Free radicals and diabetes. Free Radic. Biol. Med. 5:1988;113-124.
5. Rabinovitch A., Suarez W.L., Thomas P.D., Strynadka K., Simpson I. Cytotoxic effects of cytokines on rat islets evidence for involvement of free radicals and lipid peroxidation. Diabetologia. 35:1992;409-413.
6. Rabinovitch A. Free radicals as mediators of pancreatic islet beta-cell injury in autoimmune diabetes (editorial; comment). J. Lab. Clin. Med. 119:1992;455-456.
7. Corbett, J. A.; McDaniel, M. L. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 41:897-903; 1992.
8. Heikkila R.E., Winston B., Cohen G. Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate. Biochem. Pharmacol. 25:1976;1085-1092.
9. Tsuji A., Sakurai H. Generation of nitric oxide from streptozotocin (STZ) in the presence of copper(II) plus ascorbate implication for the development of STZ-induced diabetes. Biochem. Biophys. Res. Commun. 245:1998;11-16.
10. Kroncke, K. D.; Fehsel, K.; Sommer, A.; Rodriguez, M. L.; Kolb-Bachofen V. Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage. Biol. Chem. Hoppe. Seyler. 376:179-185; 1995.
11. Kwon N.S., Lee S.H., Choi C.S., Kho T., Lee H.S. Nitric oxide generation from streptozotocin. FASEB J. 8:1994;529-533.
12. Lenzen S., Drinkgern J., Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20:1996;463-466.
13. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 46:1997;1733-1742.
14. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell. Biol. 10:1994;405-455.
15. Baldwin A.S. Jr. The NF-kappa B and I kappa B proteins new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
16. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
17. Hoyos B., Ballard D.W., Bohnlein E., Siekevitz M., Greene W.C. Kappa B-specific DNA binding proteins role in the regulation of human interleukin-2 gene expression. Science. 244:1989;457-460.
18. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10:1990;2327-2334.
19. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., Jongeneel C.V. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med. 171:1990;35-47.
20. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
21. Miyajima T., Kotake Y. Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice. Biochem. Biophys. Res. Commun. 215:1995;114-121.
22. Carney J.M., Floyd R.A. Protection against oxidative damage to CNS by alpha-phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents a novel series of nonlipid free radical scavengers. J. Mol. Neurosci. 3:1991;47-57.
23. Floyd R.A., Carney J.M. Free radical damage to protein and DNA mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32:1992;S22-S27.
24. Cossel L., Schneider E., Kuttler B., Schmidt S., Wohlrab F., Schade J., Bochmann C. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings. Exp. Clin. Endocrinol. 85:1985;7-26.
25. Deryckere F., Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques. 16:1994;405.
26. Hevel J.M., Marletta M.A. Nitric-oxide synthase assays. Methods Enzymol. 233:1994;250-258.
27. Lowry, O.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
28. Ho E., Chen G., Bray T. Supplementation of N-Acetylcysteine inhibits NFkB activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J. 13:1999;1845-1854.
29. Kwon G., Corbett J.A., Hauser S., Hill J.R., Turk J., McDaniel M.L. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1 beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes. 47:1998;583-591.
30. Chen G.M., Bray T.M., Janzen E.G., McCay P.B. Excretion, metabolism and tissue distribution of a spin trapping agent, alpha-phenyl-N-tert-butyl-nitrone (PBN) in rats. Free Radic. Res. Commun. 9:1990;317-323.
31. Malaisse W.J. Alloxan toxicity to the pancreatic B-cell. A new hypothesis. Biochem. Pharmacol. 31:1982;3527-3534.
32. Malaisse W.J., Malaisse-Lagae F., Sener A., Pipeleers D.G. Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc. Natl. Acad. Sci. USA. 79:1982;927-930.
33. Asayama K., Nyfeler F., English D., Pilkis S.J., Burr I.M. Alloxan-induced free radical production in isolated cells. Selective effect on islet cells. Diabetes. 33:1984;1008-1011.
34. Murata M., Imada M., Inoue S., Kawanishi S. Metal-mediated DNA damage induced by diabetogenic alloxan in the presence of NADH. Free Radic. Biol. Med. 25:1998;586-595.
35. Janzen E.G., Kotake Y., Hinton R.D. Stabilities of hydroxyl radical spin adducts of PBN-type spin traps. Free Radic. Biol. Med. 12:1992;169-173.
36. Grankvist K., Marklund S., Taljedal I.B. Superoxide dismutase is a prophylactic against alloxan diabetes. Nature. 294:1981;158-160.
37. Jorns A., Tiedge M., Lenzen S., Munday R. Effect of superoxide dismutase, catalase chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro. Free Radic. Biol. Med. 26:1999;1300-1304.
38. Yamamoto H., Uchigata Y., Okamoto H. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin. Biochem. Biophys. Res. Commun. 103:1981;1014-1020.
39. Yamamoto H., Uchigata Y., Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature. 294:1981;284-286.
40. Tabatabaie T., Kotake Y., Wallis G., Jacob J.M., Floyd R.A. Spin trapping agent phenyl N-tert-butylnitrone protects against the onset of drug-induced insulin-dependent diabetes mellitus. FEBS Lett. 407:1997;148-152.
41. Kotake Y., Sang H., Miyajima T., Wallis G.L. Inhibition of NF-kappaB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). Biochim. Biophys. Acta. 1448:1998;77-84.
42. Lee J.I., Burckart G.J. Nuclear factor kappa B important transcription factor and therapeutic target. J. Clin. Pharmacol. 38:1998;981-993.
43. Jourd'heuil D., Morise Z., Conner E.M., Grisham M.B. Oxidants, transcription factors, and intestinal inflammation. J. Clin. Gastroenterol. 25:1997;S61-S72.
44. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P.A., Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97:1996;1715-1722.
45. Gilston V., Jones H.W., Soo C.C., Coumbe A., Blades S., Kaltschmidt C., Baeuerle P.A., Morris C.J., Blake D.R., Winyard P.G. NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation. Biochem. Soc. Trans. 25:1997;518S.
46. Murphy K., Haudek S.B., Thompson M., Giroir B.P. Molecular biology of septic shock. New Horiz. 6:1998;181-193.
47. De Bosscher K., Schmitz M.L., Vanden Berghe W., Plaisance S., Fiers W., Haegeman G. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA. 94:1997;13504-13509.
48. Meyer S., Kohler N.G., Joly A. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation. FEBS Lett. 413:1997;354-358.
49. Tepper M.A., Nadler S.G., Esselstyn J.M., Sterbenz K.G. Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation. J. Immunol. 155:1995;2427-2436.
50. Schwenger P., Alpert D., Skolnik E.Y., Vilcek J. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol. Cell. Biol. 18:1998;78-84.